These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30747732)

  • 1. Treatment of chemotherapy-associated cardiomyopathy.
    Cai AW; Taylor MH; Ramu B
    Curr Opin Cardiol; 2019 May; 34(3):296-302. PubMed ID: 30747732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced cardiomyopathy.
    Yusuf SW; Ilias-Khan NA; Durand JB
    Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):231-43. PubMed ID: 21506294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Cancer Therapeutics-Related Cardiac Dysfunction.
    Vallakati A; Konda B; Lenihan DJ; Baliga RR
    Heart Fail Clin; 2018 Oct; 14(4):553-567. PubMed ID: 30266364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating biomarkers for management of cancer therapeutics-related cardiac dysfunction.
    Tonry C; Russell-Hallinan A; McCune C; Collier P; Harbinson M; Dixon L; Watson CJ
    Cardiovasc Res; 2023 May; 119(3):710-728. PubMed ID: 35640873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized Approach to Cancer Treatment-Related Cardiomyopathy.
    Slivnick J; Vallakati A; Addison D; Wallner A; Tong MS
    Curr Heart Fail Rep; 2020 Apr; 17(2):43-55. PubMed ID: 32125627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-induced cardiomyopathy.
    Higgins AY; O'Halloran TD; Chang JD
    Heart Fail Rev; 2015 Nov; 20(6):721-30. PubMed ID: 26338137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart Failure Therapies for End-Stage Chemotherapy-Induced Cardiomyopathy.
    Mukku RB; Fonarow GC; Watson KE; Ajijola OA; Depasquale EC; Nsair A; Baas AS; Deng MC; Yang EH
    J Card Fail; 2016 Jun; 22(6):439-48. PubMed ID: 27109619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Ventricular Dysfunction and Chemotherapeutic Agents.
    Clasen SC; Wald JW
    Curr Cardiol Rep; 2018 Mar; 20(4):20. PubMed ID: 29520629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes: The SUCCOUR Trial.
    Negishi T; Thavendiranathan P; Negishi K; Marwick TH;
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1098-1105. PubMed ID: 29909105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Biomarkers in Cardio-Oncology.
    Ananthan K; Lyon AR
    J Cardiovasc Transl Res; 2020 Jun; 13(3):431-450. PubMed ID: 32642841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity.
    Avila MS; Siqueira SRR; Ferreira SMA; Bocchi EA
    Methodist Debakey Cardiovasc J; 2019; 15(4):267-273. PubMed ID: 31988687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyopathy Prevention in Cancer Patients.
    Barbar T; Mahmood SS; Liu JE
    Cardiol Clin; 2019 Nov; 37(4):441-447. PubMed ID: 31587785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyopathy associated with cancer therapy.
    Yu AF; Steingart RM; Fuster V
    J Card Fail; 2014 Nov; 20(11):841-52. PubMed ID: 25151211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac complications in cancer treatment - A review.
    Li X; Liu M; Sun R; Zeng Y; Chen S; Zhang P
    Hellenic J Cardiol; 2017; 58(3):190-193. PubMed ID: 28011332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure and chemotherapeutic agents.
    Piper S; McDonagh T
    Future Cardiol; 2015 Jul; 11(4):453-70. PubMed ID: 26234158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiotoxicity of Cancer Chemotherapy - Mechanisms and Therapeutic Approach].
    Akazawa H
    Gan To Kagaku Ryoho; 2017 Dec; 44(13):2058-2063. PubMed ID: 29361617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiotoxicity of cancer chemotherapy: implications for children.
    Simbre VC; Duffy SA; Dadlani GH; Miller TL; Lipshultz SE
    Paediatr Drugs; 2005; 7(3):187-202. PubMed ID: 15977964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiotoxicity of cancer therapy].
    Marek J; Linhart A; Rucklová Z; Haber J; Korínek J
    Vnitr Lek; 2011 May; 57(5):472-84. PubMed ID: 21695928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Cardiac Imaging Modalities for the Early Detection of Cardiotoxicity Due to Anticancer Therapies.
    López-Fernández T; Thavendiranathan P
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):487-495. PubMed ID: 28189542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardio-oncology Part I: chemotherapy and cardiovascular toxicity.
    O'Hare M; Sharma A; Murphy K; Mookadam F; Lee H
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):511-8. PubMed ID: 25843285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.